| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0115521552688258 | 0.29717976 |
| NSC 733906 | Null | 0.0115521552688258 | -0.091754201 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0115521552688258 | -0.13227977 |
| NSC 741942 | Null | 0.0115521552688258 | 0.10278527 |
| NSC 176327 | Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride | 0.0123744972338278 | -0.041599529 |
| NSC 46401 | .alpha.-Sarcin | 0.0123744972338278 | -0.096751344 |
| NSC 59220 | [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt | 0.0123744972338278 | 0.10428885 |
| NSC 624659 | ANTINEOPLASTIC-624659 | 0.0123744972338278 | 0.42662503 |
| NSC 625500 | Null | 0.0123744972338278 | 0.31438142 |
| NSC 643419 | Null | 0.0123744972338278 | -0.21476015 |